Rare Diseases SA has been actively improving the quality of life for those impacted by Rare Diseases over the last 5 years.
Our key focus areas have remained advocacy, patient navigation and community engagement, and through these strategic objectives we have successfully managed to see positive impact in our community.
From the development of over 80 patient connect points, to the implementation of a mobile app, RDSA has ensured patients remain supported and connected whilst the organization remains focused on our advocacy efforts.
The successful roll-out of our Rare Assist service has also seen a reduction in out of pocket costs for patients in the private sector.
We have attached our 5 year impact report which demonstrates some of the impact our work has had within our community. We have also included our programme overview of the Rare Assist Programme.
We would love to have your feedback on these reports, as well as feedback on the following questions:
1. What interest do you have with our organisation?
2. What is your current opinion on our work?
3. How would you like to stay informed about what we do?
4. What motivates you to stay connected with us?
Should you have any questions for us, we would love to hear from you.
Kind Regards
Kelly du Plessis
CEO -Rare Diseases South Africa
info@rarediseases.co.za
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Variome Project
This document discusses challenges for low and middle income countries regarding human genomics and public health in a global context. It notes that while genomics activity is increasing in about 50 countries, it remains fragmented without systematic monitoring or links to health policymakers. Five priorities for international genomics are identified: building an evidence base for genomic medicine, addressing health disparities, managing diverse patient populations, implications for medical education, and coordination across diseases. The document argues for greater global collaboration to improve access, establish standards, and promote equity and justice.
The document discusses strategies to reduce the burden of liver disease in the Philippines through hepatitis vaccination and prevention of liver cancer. It outlines the Hepatology Society of the Philippines' strategic focus on research, education, advocacy, and policy formulation to address hepatitis. The summary focuses on key areas of the WHO global hepatitis framework that the HSP plan aligns with and policy levers to support change through advocacy, education, and evidence-based policy development.
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
1) The document summarizes a study and intervention program aimed at reducing HIV/STI risk for men who have sex with men (MSW) in Mombasa, Kenya.
2) The study found high risk sexual behaviors, STIs, and barriers to healthcare access among MSW due to stigma.
3) The intervention included peer education, condom/lubricant distribution, healthcare provider training, counseling, and testing services through an MSW drop-in center.
4) Preliminary results showed increased knowledge, safer behaviors, and service uptake, though challenges around sustainability and addressing needs of a hidden population remained.
The Joint Learning Network in Action: Spotlight on GhanaHFG Project
More and more countries are implementing complex health systems reforms to achieve universal health coverage. The Joint Learning Network (JLN) is a country-driven network of practitioners and policymakers who together develop knowledge products to bridge the gap between theory and practice, with the goal of extending health care coverage to more than 3 billion people.
The JLN community is comprised of leaders from ministries of health, national health financing agencies, and other key government institutions in 27 Asian, African, European, Latin American, and Middle Eastern countries as well as a diverse group of international, regional, and local partners.
On Thursday, September 22, the HFG Project hosted a technical briefing session on the JLN's work on the ground, and about Ghana’s National Health Insurance Authority (NHIA) on their collaboration with the JLN and the HFG project. Speakers included: Amanda Folsom (JLN Program Director, Results for Development), Nathaniel Otoo, (Chief Executive, Ghana NHIA), Dr. Lydia Dsane-Selby (Director, Claims, NHIA), and Chris Lovelace (Principal Associate, International Health, Abt Associates).
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Variome Project
This document discusses challenges for low and middle income countries regarding human genomics and public health in a global context. It notes that while genomics activity is increasing in about 50 countries, it remains fragmented without systematic monitoring or links to health policymakers. Five priorities for international genomics are identified: building an evidence base for genomic medicine, addressing health disparities, managing diverse patient populations, implications for medical education, and coordination across diseases. The document argues for greater global collaboration to improve access, establish standards, and promote equity and justice.
The document discusses strategies to reduce the burden of liver disease in the Philippines through hepatitis vaccination and prevention of liver cancer. It outlines the Hepatology Society of the Philippines' strategic focus on research, education, advocacy, and policy formulation to address hepatitis. The summary focuses on key areas of the WHO global hepatitis framework that the HSP plan aligns with and policy levers to support change through advocacy, education, and evidence-based policy development.
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
1) The document summarizes a study and intervention program aimed at reducing HIV/STI risk for men who have sex with men (MSW) in Mombasa, Kenya.
2) The study found high risk sexual behaviors, STIs, and barriers to healthcare access among MSW due to stigma.
3) The intervention included peer education, condom/lubricant distribution, healthcare provider training, counseling, and testing services through an MSW drop-in center.
4) Preliminary results showed increased knowledge, safer behaviors, and service uptake, though challenges around sustainability and addressing needs of a hidden population remained.
The Joint Learning Network in Action: Spotlight on GhanaHFG Project
More and more countries are implementing complex health systems reforms to achieve universal health coverage. The Joint Learning Network (JLN) is a country-driven network of practitioners and policymakers who together develop knowledge products to bridge the gap between theory and practice, with the goal of extending health care coverage to more than 3 billion people.
The JLN community is comprised of leaders from ministries of health, national health financing agencies, and other key government institutions in 27 Asian, African, European, Latin American, and Middle Eastern countries as well as a diverse group of international, regional, and local partners.
On Thursday, September 22, the HFG Project hosted a technical briefing session on the JLN's work on the ground, and about Ghana’s National Health Insurance Authority (NHIA) on their collaboration with the JLN and the HFG project. Speakers included: Amanda Folsom (JLN Program Director, Results for Development), Nathaniel Otoo, (Chief Executive, Ghana NHIA), Dr. Lydia Dsane-Selby (Director, Claims, NHIA), and Chris Lovelace (Principal Associate, International Health, Abt Associates).
The document summarizes survey responses from health organizations in East Africa on decision-making and decision support tools. Respondents said participatory approaches, environmental and socioeconomic factors, and available scientific data are important in decision-making. Challenges include sustaining vector control and prioritizing surveillance. Respondents need information on disease trends, costs and benefits of options, and maps of endemicity, vulnerability, and hazards. Uncertainty complicates decisions due to incomplete knowledge, conflicting views, and unpredictability. Uncertainty is addressed through stakeholder consultation, scenario analysis, and surveillance data. Decisions are needed at local to international levels over timeframes from months to decades.
This document summarizes evidence-informed health care for rare diseases. It discusses:
1) Progress in rare disease research including increasing genetic tests available and approved orphan drugs. Clinical interventions and systems of care are important.
2) Why studying systems of care is important to reduce the "effectiveness gap" between clinical trials and real-world outcomes. Translational research from efficacy to effectiveness and population impact is needed.
3) Challenges in studying rare disease care including limited knowledge, defining meaningful outcomes, and study feasibility with small patient numbers. International collaboration is key.
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The document introduces the HCV HUB, a knowledge management platform created to address the global hepatitis C virus (HCV) epidemic. The HCV HUB aims to [1] collect up-to-date HCV information and resources in one centralized location, [2] connect users with the global HCV community, and [3] facilitate HCV knowledge exchange and learning from international experiences. Content is organized into tools, case studies, interventions, action plans, and publications. The HCV HUB is intended to support a variety of HCV stakeholders, including government agencies, payers, researchers, and community groups, in developing and improving HCV prevention, treatment, and control plans.
The document summarizes an HCV HUB, which is an online knowledge management platform created to address the global HCV epidemic. It collects up-to-date information and resources on HCV prevention, treatment and control from various stakeholders in one centralized location. The objective of the HCV HUB is to support users and their organizations by allowing them to collect relevant information, connect with the global HCV community, and learn from international experiences. Content is organized into tools, case studies, interventions and other resources. The HCV HUB is intended to help a wide range of stakeholders, including healthcare professionals, develop and improve HCV plans and interventions.
The document summarizes an HCV HUB, which is a knowledge management platform that centralizes up-to-date information on hepatitis C virus (HCV) from various stakeholders. The HCV HUB aims to support organizations and communities in planning and implementing HCV cure and control strategies. It allows users to collect relevant HCV publications and resources, connect with the global HCV community, and learn from other experiences. Content is organized into tools, case studies, interventions, action plans, and publications. The HCV HUB is intended to benefit various stakeholders, including patient associations for advocacy efforts.
HCV HUB planning and implementation website introduction with a specific focus on the benefits provided to scientific societies. http://hcvhub.deusto.es
The document introduces the HCV HUB, a knowledge management platform created to address the global hepatitis C virus (HCV) epidemic. The HCV HUB aims to [1] collect up-to-date HCV information and resources in one centralized location, [2] connect users with the global HCV community, and [3] facilitate HCV knowledge exchange to support efforts to cure and control HCV worldwide. Content on the HCV HUB is organized and covers a range of topics including interventions, case studies, publications, and action plans. The HCV HUB is intended to be a useful resource for various stakeholders interested in improving HCV management, including policymakers, health professionals, and community organizations.
How Community Engagement Fits Into The Mission Of The National Center for Adv...SC CTSI at USC and CHLA
NCATS aims to catalyze biomedical innovation to improve human health. It focuses on developing and testing new interventions, demonstrating their effectiveness, and disseminating them to improve public health. NCATS emphasizes community engagement throughout the translational research process to ensure research addresses important health issues. Through programs like the CTSA consortium and ORDR, NCATS facilitates collaboration between researchers and patient communities. Moving forward, NCATS will focus on innovating community engagement methods and measuring their impact on research and outcomes.
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The Canadian Hemophilia Society advocated for access to the innovative drug emicizumab (Hemlibra) for Canadians with hemophilia A between 2018-2021. After initial delays, the drug was approved for patients with inhibitors in May 2019 but advocacy continued for broader access. Health technology assessments recommended against funding due to perceived lack of evidence, though patients reported a high disease burden. Advocacy efforts included surveys, letters, media stories, and behind-the-scenes discussions. In August 2021, Quebec partially approved funding while the rest of Canada approved broader public funding in September 2021.
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...Human Variome Project
The document discusses the Global Globin 2020 Challenge which aims to increase genetic data sharing related to hemoglobinopathies from low and middle-income countries. The three goals are to grow quality genetic database inputs from these countries, harmonize data sharing between countries according to ethical standards, and ensure sustainable medium-term data storage, curation and sharing by strengthening international professional networks. It provides background on the high prevalence of hemoglobin disorders like sickle cell disease in Africa and challenges in diagnosis and treatment. The challenge will work to raise awareness, integrate new technologies into healthcare, and achieve cross-country cooperation and knowledge sharing to address hemoglobinopathies and genomic medicine more broadly.
Health information Seminar - Dr Derick Mitchell - Oct 2017ipposi
This document summarizes discussions from an IPPOSI (Influencing Policy, Activating Patients, Harnessing Industry) event on patient involvement in health innovation.
IPPOSI is a patient-led organization that advocates for improved patient access to health innovation by promoting meaningful patient involvement in health research and policy. The event discussed how patient voices are changing health innovation through surveys and the EUPATI program which trains patients as experts in medical research. National platforms in many European countries have been established through EUPATI to address educational needs and disseminate training. Patient roles and leadership have increased as a result of the EUPATI course. A roadmap was presented on how patients can be involved at different stages of the
The ONE Project was an oncology nurses' education project conducted in May 2014 in Bahrain. It aimed to provide educational programs targeting oncology nurses to improve their disease awareness, adverse event management skills, and ability to improve patient outcomes. Over 30 nurses attended educational sessions on various cancer types and management of adverse events from Roche's oncology portfolio. The project received positive feedback and was accredited by the Ministry of Health. It established Roche as committed to raising disease awareness and opened opportunities for future patient access programs.
The document discusses Project ECHO and its mission to expand access to specialty healthcare for common and complex diseases in rural and underserved areas. Project ECHO uses teleconferencing and case-based learning to train primary care clinicians to treat and manage conditions like hepatitis C. An evaluation showed primary care clinicians trained through Project ECHO achieved similar treatment outcomes for hepatitis C as specialists at a university medical center, improving access to care for rural and minority populations.
This document discusses the Heartland Telehealth Resource Center (HTRC), which provides technical assistance and resources to implement telehealth programs for rural and underserved communities in Kansas, Missouri, and Oklahoma. It is one of 14 regional telehealth centers funded by the U.S. Department of Health and Human Services. The HTRC works with rural communities, community health centers, and rural health clinics to help organizations overcome barriers and advance telehealth education. It provides consultation services, webinars, workshops and online resources to support telehealth implementation. The document also describes several telehealth programs operated by the University of Kansas Medical Center that provide behavioral health services to children, schools and disaster-affected communities using a telehealth model.
CER 2016 Nguyen ctsi collaborative researchCTSI at UCSF
This document describes the Health Within Reach project, a collaborative effort between UCSF, SFGH, and SF Hep B Free to improve hepatitis B and C screening for Asian Americans. The team was formed due to their shared focus on Asian American health disparities and complementary expertise in clinical research, community engagement, and multi-lingual interventions. Challenges in collaborating across organizations were addressed through regular communication, consensus decision-making, and flexibility. The project aims to develop and evaluate a video and provider alert intervention to increase screening rates.
Canada’s Rare Disease Drug Program
Vision: Integrated, Inclusive, Innovative Rare Drug System
Single Seamless Pathway from R&D, CT, regulatory approval, access parameters, monitoring, values-based assessment, price negotiations
Governance board representing all stakeholders: diverse patient community, clinical specialities, public/private drug plan providers, HTA agencies, pharmaceutical companies, subject matter experts (regulatory, research)
Building for Success: 12 Steps, 4 Platforms
A presentation delivered by Derick Mitchell, IPPOSI CEO at the event to celebrate International Clinical Trials Day on May 10th, 2018 in the Mansion House, Dublin, organised by HRB-CRCI.
The document summarizes survey responses from health organizations in East Africa on decision-making and decision support tools. Respondents said participatory approaches, environmental and socioeconomic factors, and available scientific data are important in decision-making. Challenges include sustaining vector control and prioritizing surveillance. Respondents need information on disease trends, costs and benefits of options, and maps of endemicity, vulnerability, and hazards. Uncertainty complicates decisions due to incomplete knowledge, conflicting views, and unpredictability. Uncertainty is addressed through stakeholder consultation, scenario analysis, and surveillance data. Decisions are needed at local to international levels over timeframes from months to decades.
This document summarizes evidence-informed health care for rare diseases. It discusses:
1) Progress in rare disease research including increasing genetic tests available and approved orphan drugs. Clinical interventions and systems of care are important.
2) Why studying systems of care is important to reduce the "effectiveness gap" between clinical trials and real-world outcomes. Translational research from efficacy to effectiveness and population impact is needed.
3) Challenges in studying rare disease care including limited knowledge, defining meaningful outcomes, and study feasibility with small patient numbers. International collaboration is key.
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The document introduces the HCV HUB, a knowledge management platform created to address the global hepatitis C virus (HCV) epidemic. The HCV HUB aims to [1] collect up-to-date HCV information and resources in one centralized location, [2] connect users with the global HCV community, and [3] facilitate HCV knowledge exchange and learning from international experiences. Content is organized into tools, case studies, interventions, action plans, and publications. The HCV HUB is intended to support a variety of HCV stakeholders, including government agencies, payers, researchers, and community groups, in developing and improving HCV prevention, treatment, and control plans.
The document summarizes an HCV HUB, which is an online knowledge management platform created to address the global HCV epidemic. It collects up-to-date information and resources on HCV prevention, treatment and control from various stakeholders in one centralized location. The objective of the HCV HUB is to support users and their organizations by allowing them to collect relevant information, connect with the global HCV community, and learn from international experiences. Content is organized into tools, case studies, interventions and other resources. The HCV HUB is intended to help a wide range of stakeholders, including healthcare professionals, develop and improve HCV plans and interventions.
The document summarizes an HCV HUB, which is a knowledge management platform that centralizes up-to-date information on hepatitis C virus (HCV) from various stakeholders. The HCV HUB aims to support organizations and communities in planning and implementing HCV cure and control strategies. It allows users to collect relevant HCV publications and resources, connect with the global HCV community, and learn from other experiences. Content is organized into tools, case studies, interventions, action plans, and publications. The HCV HUB is intended to benefit various stakeholders, including patient associations for advocacy efforts.
HCV HUB planning and implementation website introduction with a specific focus on the benefits provided to scientific societies. http://hcvhub.deusto.es
The document introduces the HCV HUB, a knowledge management platform created to address the global hepatitis C virus (HCV) epidemic. The HCV HUB aims to [1] collect up-to-date HCV information and resources in one centralized location, [2] connect users with the global HCV community, and [3] facilitate HCV knowledge exchange to support efforts to cure and control HCV worldwide. Content on the HCV HUB is organized and covers a range of topics including interventions, case studies, publications, and action plans. The HCV HUB is intended to be a useful resource for various stakeholders interested in improving HCV management, including policymakers, health professionals, and community organizations.
How Community Engagement Fits Into The Mission Of The National Center for Adv...SC CTSI at USC and CHLA
NCATS aims to catalyze biomedical innovation to improve human health. It focuses on developing and testing new interventions, demonstrating their effectiveness, and disseminating them to improve public health. NCATS emphasizes community engagement throughout the translational research process to ensure research addresses important health issues. Through programs like the CTSA consortium and ORDR, NCATS facilitates collaboration between researchers and patient communities. Moving forward, NCATS will focus on innovating community engagement methods and measuring their impact on research and outcomes.
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The Canadian Hemophilia Society advocated for access to the innovative drug emicizumab (Hemlibra) for Canadians with hemophilia A between 2018-2021. After initial delays, the drug was approved for patients with inhibitors in May 2019 but advocacy continued for broader access. Health technology assessments recommended against funding due to perceived lack of evidence, though patients reported a high disease burden. Advocacy efforts included surveys, letters, media stories, and behind-the-scenes discussions. In August 2021, Quebec partially approved funding while the rest of Canada approved broader public funding in September 2021.
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...Human Variome Project
The document discusses the Global Globin 2020 Challenge which aims to increase genetic data sharing related to hemoglobinopathies from low and middle-income countries. The three goals are to grow quality genetic database inputs from these countries, harmonize data sharing between countries according to ethical standards, and ensure sustainable medium-term data storage, curation and sharing by strengthening international professional networks. It provides background on the high prevalence of hemoglobin disorders like sickle cell disease in Africa and challenges in diagnosis and treatment. The challenge will work to raise awareness, integrate new technologies into healthcare, and achieve cross-country cooperation and knowledge sharing to address hemoglobinopathies and genomic medicine more broadly.
Health information Seminar - Dr Derick Mitchell - Oct 2017ipposi
This document summarizes discussions from an IPPOSI (Influencing Policy, Activating Patients, Harnessing Industry) event on patient involvement in health innovation.
IPPOSI is a patient-led organization that advocates for improved patient access to health innovation by promoting meaningful patient involvement in health research and policy. The event discussed how patient voices are changing health innovation through surveys and the EUPATI program which trains patients as experts in medical research. National platforms in many European countries have been established through EUPATI to address educational needs and disseminate training. Patient roles and leadership have increased as a result of the EUPATI course. A roadmap was presented on how patients can be involved at different stages of the
The ONE Project was an oncology nurses' education project conducted in May 2014 in Bahrain. It aimed to provide educational programs targeting oncology nurses to improve their disease awareness, adverse event management skills, and ability to improve patient outcomes. Over 30 nurses attended educational sessions on various cancer types and management of adverse events from Roche's oncology portfolio. The project received positive feedback and was accredited by the Ministry of Health. It established Roche as committed to raising disease awareness and opened opportunities for future patient access programs.
The document discusses Project ECHO and its mission to expand access to specialty healthcare for common and complex diseases in rural and underserved areas. Project ECHO uses teleconferencing and case-based learning to train primary care clinicians to treat and manage conditions like hepatitis C. An evaluation showed primary care clinicians trained through Project ECHO achieved similar treatment outcomes for hepatitis C as specialists at a university medical center, improving access to care for rural and minority populations.
This document discusses the Heartland Telehealth Resource Center (HTRC), which provides technical assistance and resources to implement telehealth programs for rural and underserved communities in Kansas, Missouri, and Oklahoma. It is one of 14 regional telehealth centers funded by the U.S. Department of Health and Human Services. The HTRC works with rural communities, community health centers, and rural health clinics to help organizations overcome barriers and advance telehealth education. It provides consultation services, webinars, workshops and online resources to support telehealth implementation. The document also describes several telehealth programs operated by the University of Kansas Medical Center that provide behavioral health services to children, schools and disaster-affected communities using a telehealth model.
CER 2016 Nguyen ctsi collaborative researchCTSI at UCSF
This document describes the Health Within Reach project, a collaborative effort between UCSF, SFGH, and SF Hep B Free to improve hepatitis B and C screening for Asian Americans. The team was formed due to their shared focus on Asian American health disparities and complementary expertise in clinical research, community engagement, and multi-lingual interventions. Challenges in collaborating across organizations were addressed through regular communication, consensus decision-making, and flexibility. The project aims to develop and evaluate a video and provider alert intervention to increase screening rates.
Canada’s Rare Disease Drug Program
Vision: Integrated, Inclusive, Innovative Rare Drug System
Single Seamless Pathway from R&D, CT, regulatory approval, access parameters, monitoring, values-based assessment, price negotiations
Governance board representing all stakeholders: diverse patient community, clinical specialities, public/private drug plan providers, HTA agencies, pharmaceutical companies, subject matter experts (regulatory, research)
Building for Success: 12 Steps, 4 Platforms
A presentation delivered by Derick Mitchell, IPPOSI CEO at the event to celebrate International Clinical Trials Day on May 10th, 2018 in the Mansion House, Dublin, organised by HRB-CRCI.
PPI Summer School, UL - Laura Kavanagh - June 2017ipposi
This document discusses patient involvement in health innovation and research. It introduces IPPOSI, a patient-led organization that advocates for improved patient access to health innovation and meaningful patient involvement in health research and policy. IPPOSI runs various patient-led activities and provides training to educate patient communities. The EUPATI program also trains "expert patients" on medicines research and development to take on leadership roles advising organizations. While challenges remain, patient involvement can provide different perspectives to improve research quality by ensuring methods and outcomes important to patients are considered. Education and training of both patients and researchers is key to furthering patient involvement.
Geneva Pharma Forum on Pharmacovigilance: Partnering for
Patient Safety (Geneva, 20 November 2012), Jeremiah Mwangi, Director, Policy and External Affairs, IAPO
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
● Discussion of the CADTH Symposium
● Recommendations for HTA improvements in Canada
● Audience Q&A
View the video: https://youtu.be/AJCOemf2r6Y
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
A presentation delivered by IPPOSI CEO, Derick Mitchell at the University College Dublin PharmTox Society event on Clinical Trials in Ireland on March 6th, 2017
Rare Disease Patient Registries:
Key to Drug Development and Access
Tuesday, May 3 @ 12:00 – 1:00 pm EDT
Slides:
USA National Institutes of Health RaDaR
NORD IAMRARE (Pam Gavin, VP)
Canada INFORM RARE (Beth Potter, CHEO; Pranesh Chakraborty, CHEO; Kim Angel, Can MPS Society; John Adams, CanPKU)
The document summarizes the Winterbourne Medicines Programme, which was established to investigate concerns about the overuse of antipsychotic and antidepressant medications for people with learning disabilities. Six NHS foundation trusts partnered with NHS Improving Quality to better understand current medication practices and test improvements over six months. The program aimed to ensure medications are used safely and appropriately for this patient population.
Outcome of the online consultation of USAID, Aligning Research Investments to...Francois Stepman
18-20 April 2017. Aligning Research Investments to the Global Food Security Strategy (GFSS): A Three-Day AgExchange on Nutrition, Resilience and Agriculture-Led Economic Growth
Over 400 development and research professionals in more than 30 countries followed and/or contributed to the discussion on research investments in resilience, nutrition, and agriculture-led economic growth. A team of experts is currently carefully reviewing each and every comment to inform the drafting of the GFSS research strategy.
A experiência do Reino Unido sobre as Práticas Avançadas em Enfermagem foi tema da última reunião virtual, que aconteceu nesta quarta (24/11), do ciclo de intercâmbio promovido pela Organização Pan-Americana da Saúde no Brasil, pelo Conselho Federal de Enfermagem (Cofen) e pelo Centro Colaborador da OPAS/OMS para o Desenvolvimento da Pesquisa em Enfermagem da Universidade de São Paulo/Ribeirão. As palestrantes foram a diretora e a presidente do International Council of Nurses (ICN) do Reino Unido, Melaine Roger e Daniela Lehwaldt, respectivamente. Elas abordaram os avanços globais nas práticas em enfermagem, trouxeram casos do que acontece no Reino Unido e o porquê da importância dos enfermeiros e enfermeiras em práticas avançadas para os sistemas universais de saúde.
Clinical interactions and communication are key factors for improving chronic disease self-management for Aboriginal and Torres Strait Islander peoples with rheumatic heart disease. Improving communication requires effective two-way and cross-cultural communication between patients, community members, and healthcare providers. Strategies like clinical yarning and developing cultural health capital can help build rapport and understanding between patients and providers to support self-management. Addressing social and cultural factors is important for meaningful patient-provider interactions and successful self-management.
PPI Conference Galway April 2017 - Dr Derick Mitchellipposi
This document summarizes the work of IPPOSI, a patient-led organization in Ireland that advocates for meaningful patient involvement in health research and policy. It discusses IPPOSI's priorities such as advocating for improved patient access to health innovation and promoting patient involvement in research and policy. It also outlines IPPOSI's activities like workshops and conferences. The document notes IPPOSI's role in several national initiatives in Ireland relating to mental health, clinical research, and health policy. It discusses the impact of the EUPATI training course in building patient leadership capacity in Ireland and other European countries.
Improving quality, safety and lives - the Patient Safety Collaborative Programme 2014-2019
Presentation from Chief Nursing Officer for England's Summit 2014
26 November 2014
Advocacy Workshop, National Rx Drug Abuse Summit, April 2-4, 2013. Advocacy Workshop: Successful Strategies for Community Change - Part 1 presentation by Dr. Sarah Melton and Dr. Andrew Kolodny.
The document provides an overview of the International Psoriasis Council (IPC) and their partnership with ILDS and IFPA to execute the Global Psoriasis Atlas project. The IPC is a nonprofit organization comprised of the world's leading experts in psoriasis. They aim to advance knowledge of psoriasis and enhance patient care through research, education, and clinical practice guidelines. The document notes that worldwide prevalence and incidence of psoriasis is poorly understood currently. The Global Psoriasis Atlas project aims to address this through collecting epidemiological data on psoriasis prevalence, burden, and natural history across countries to inform policy and improve care.
Bringing the patient voice into GSK for educational, awareness and patient ce...Nowgen
"Bringing the patient voice into GlaxoSmithKline for educational, awareness and patient centred decisions within medicine development", presented by Kay Warner, Global Manager, Focus on the Patient, GlaxoSmithKline, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
Medical students taking the elective course in rare diseases are provided a number of patient perspectives throughout the module. This is what IPPOSI presented in 2017.
Similar to 5 year impact report for Rare Diseases (20)
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
3. Stakeholder Meeting – 27 Feb 2019
Premier Hotel, Johannesburg
Key Findings
• The need for an accepted definition of a rare disease
• The rigid regulations in terms of SEP pricing are inhibiting innovation in terms of market access
• Lengthily drug registration processes are inhibiting appropriate and timeous access
• Robust discussion and engagement on innovative access models are required
• The legal interpretation of existing law is variable
• Regulators need to ensure compliance of appropriate decisions on PMB legislation
• Exemption guidelines for evidence-based evaluation and drug registrations are needed
• Improved patient advocacy and patient participation is required in healthcare sector
• New-born screening is a possible cost-effective approach to early identification of treatable conditions
• There is disparity between access between different medical schemes as well as the state and private sector
• Further engagement is needed on a continuous basis
RDSA undertook to host a meeting engaging with all stakeholders within the private sector of healthcare, to
discuss the access challenges currently faced by members within the rare disease community
OBJECTIVES
• Gather and forge linkages between key, relevant stakeholders with a common interest in improving access to
treatments for those impacted by rare diseases
• Provide a comprehensive overview of the rare disease access challenges within the healthcare sector
• Identify lessons learned and develop a way forward
IMPACT
Private Sector multi
stakeholder Forum
launched to address Rare
Disease challenges
across the sector.
4. Alliance and Partnership Development
Key Alliances and Partnerships
• Rare Diseases International
• Eurordis
• IRDiRC
• Africa-Rare.Org
• IAPO
• SAHTAC
• Genetic Alliance SA
• Childhood Cancer Network SA
• Palliative Care network (PATCH / ICPCN)
• Rare Diseases Africa Advisory Group
RDSA has entered into various collaborative alliances and partnerships with organizations aimed at improving
the health care sector, and Rare Diseases across the globe.
• Improved collaborative efforts across the health sector
• Improved advocacy
• Increased capacity and visibility
• International and regional participation
IMPACT
5. Legislative Input
Legislative and policy input
• Presidential Health Compact
• PMB Review Process at Council for Medical Schemes
• SAHPRA Guidelines for section 21 access
• Genetic Guidelines drafted at NDOH
• NHI Bill
• Medical Schemes Amendment Bill
• ASSAF consensus on genomics
• Chronic Illness in Schools education policy
• Universal Health Care atWHO / United Nations
RDSA has provided input and feedback in various legislative
and policy reviews across South Africa and
internationally.
IMPACT
• Improved collaborative efforts across the health sector
• Improved advocacy
• Increased capacity and visibility
• International and regional participation
• United patient voice
6. Conference Participation
Role of patient organizations - University of Pretoria Metabolic Symposium, Pretoria, SouthAfrica, 2013
Where we have come from and where we are going - Gaucher Symposium, Johannesburg, SouthAfrica, 2014
The Big Debate: ethically acceptable or unacceptable social consequences - Paediatric Refresher Course, CapeTown, 2016
Re-inventing the future for Rare Disease patients – Pompe Symposium, Johannesburg, South Africa, 2015
Rare diseases from a parent’s perspective - ICORD, Mexico City, Mexico, 2015
The need for innovative thinking to treat Rare Diseases in Africa – SAPHEX, Johannesburg, South Africa, 2016
Private Practice: The good, the bad and the Ugly – UpToSPAED, Johannesburg,SouthAfrica, 2017
The Need for collaboration in the Rare Disease environment – Pfizer Symposium, Johannesburg, SouthAfrica, 2017
Challenges of Rare Diseases in developing countries – Rare Diseases International, Madrid, Spain, 2017
The need for long term sustainable solutions - Sanofi Scientific Forum – Magaliesburg, South Africa, 2017
The Status Quo of Rare Diseases – World Orphan DrugCongress,Washington, USA, 2016
Keynote Address: Palliative Care in Rare Diseases: are we swimming upstream? ICPCN Conference, Durban, SouthAfrica, 2018
The Long term impact of Rare Diseases - Fabry Symposium – Shire, Johannesburg / Durban / CapeTown, South Africa, 2018
Keynote Address: The Multidisciplinary Approach – RareX, Johannesburg, South Africa, 2018
United Nations: Rare Diseases in South Africa – NewYork, USA, 2019
Kelly du Plessis,CEO of Rare Diseases has presented on various subjects at a variety of international and national
conferences.
• Improved collaborative efforts across the health sector
• Education of HCPs and Stakeholders on the plight of Rare Disease patients
• Increased funding
• International and regional participation
• Sharing of best practice and expertise
IMPACT
8. Delegates
• 2016 182 Attendees
• 2018: 125 Attendees
• 2016: 16 Support Groups
• 2018: 19 Support Groups
Sessions
• Genetic Landscape in South Africa
• Inborn Errors of Metabolism
• Palliative Care in South Africa
• Diagnostic availability
• Global rare disease policies and programmes
• Access to treatment
• Research and Funding
• Improved quality of life approaches
• Patient Organizations
• Capacity Building with Rare Diseases Int.
RareX Bi-Annual Conference (2016 - Cape Town / 2018 - Johannesburg)
Post Event Feedback
• 48 Submitted Abstracts
• 89% of respondents said the
technical information gained
was good.
• 93% said the practical
information gained was great
• 90% said new ideas were
gained
• 82% enjoyed the timing of the
discussion periods
“I took home a tremendous amount of knowledge,
which was worth the travel and time. I think that many
more conferences could benefit from all the diverse,
participatory and collaborative approach which was
adopted during this event.”
RareX 2016 Delegate
Africa, 72%
Europe, 17%
North
America,
7%
South
America,
3%
Australasia,
1%
CONTINENTS
PAGs
30%
HCPs
27%
Academia
17%
Industry
14%
Patients
7%
Authorities
5%
DELEGATESTheme: The need for a multidisciplinary approach
IMPACT
• Created patient centric approach
• Educated patients and caregivers, HCPs and policy makers
• Sharing of best practices
• Connected the community
9. Speakers:
• Kay A. Toomey, PhD - Pediatric Psychologist; President ofToomey
& Associates, Inc.; Clinical Director of SOS Feeding Solutions at
STAR Institute for Sensory Processing Disorder
• Erin S. Ross, PhD, CCC-SLP - Neonatal and Pediatric Speech
Pathologist; Assistant Clinical Professor at University of
Colorado; Faculty at Rocky Mountain University of Health
Professions; President, Feeding FUNdamentals, LLC
Delegates: 92 CPD Points: 32 points
SOS Feeding Course – 21-24 August, The Capital Hotel, Sandton
Course Objectives
• Identify oral, sensory, motor, cognitive and emotional
developmental milestones key to feeding.
• Recognize and describe the major reasons why children won’t eat,
as based on learning theory principles.
• Identify physical, behavioural, motor, oral-motor, and sensory
factors as a part of a Feeding Assessment.
• Apply behavioural and social learning principles, and systematic
desensitization to feeding problems.
• Create and implement a SOS feeding program for babies, toddlers
and young children, in group and individual treatment formats.
• Improved knowledge base for HCPs working with rare disease patients who are fussy feeders and not able
to gain optimum nutrition
• Improved patient centric approach
In partnership with Sandton Feeding Centre
The Sequential Oral Sensory (S.O.S) Approach to Feeding conference is a trans-disciplinary program for assessing and treating
children with feeding difficulties and weight/growth problems from birth to 18 years. It integrates posture, sensory, motor,
behavioural/learning, medical, and nutritional factors to comprehensively evaluate and manage children with feeding/growth
problems.
IMPACT
10. RDSA, in partnership with B Braun Medical developed a pilot port access training
program for patients, caregivers and nursing professionals.
• Build awareness on ports and
• Educate delegates on the correct ways of using a port
• Connect and educate our key influencers
(doctors/nurses) that influence the patients end
decision.
Key speakers included:
• Kelly Du Plessis (CEO RDSA)
• Paul Gardiner (Past CEO of Discovery Homecare)
• Phindile Llale (B Braun representative)
• Sr. Andile Zwane (Registered Nurse)
Pilot PortTraining in partnership with B Braun Medical
KEY LEARNINGS PRIORTOWORKSHOP
• 70% of Rare Disease patients that require
long-term IV treatment, of which 42,8%
do not know what a portocath is.
• ½ the patients using a port have had an
infection
• Almost all patients using a port have not
had formal training on how to use a port
IMPACT
OBJECTIVES
How many were trained: 20 delegates
Who was trained: Patients, nurses, HCPs
• Provided responsible, patient-centred approach to
long-term IV access
• Reduced risk of infection for users
• Improved nurses / HCP ability to access ports
11. GOAL: A monthly online education platform aimed at educating those within our community around a variety of topics.
#WebinarWednesdays
• Improved patient and community education
• Increased support for those impacted by Rare Diseases
• Improve referral pathways
IMPACT
Topic Speakers Objectives
Compassion Fatigue Kim Ballantine: Professional Business and Life Coach,
Industrial Psychologist, Motivational Speaker @ Camber
Coaching
• Increase self awareness around compassion fatigue and associated symptoms
• Provide coping skills to caregivers impacted by burnout
Navigating Healthcare
(Launch of Rare Assist)
Jerome Pillay: Strategic Risk Assessor @ Rare Assist
Aneesa Ally: Strategic Risk Assessor @ Rare Assist
• Improve patient understanding on reimbursement process at Schemes
• Provide platform for patients to escalate claims
• Improve knowledge around PMBs and Formularies
FindingYourVoice Claudia Ferguson: Business Director @ Orange Ink PR
Megan Hunter: Rare Disease Ambassador
Roxy Burger: TV Personality and Celebrity Blogger
• Assist patients and champions in developing key messaging for media
• Encourage patients to find their voice and share their story
• Ensure patients are well placed to engage media on impact of rare diseases
Ehlers-Danlos Syndrome Lara Bloom: Executive Director, International @The
Ehlers-Danlos Society
Dr Alan Hakim: Rheumatologist, United Kingdom
• hEDS Patient Registry education
• Improve understanding on supportive care for EDS
• Understanding the genetics around EDS
Terminal Illness? What to
consider…
Dr Mehnaaz Akbar Ally: Paediatric Palliative Care
Practitioner @WitsPal & Lambano Sanctuary
Adv Bonnie Venter: Legal Affairs @Transplant Education for
Living Legacies (TELL)
Petra Burger: Social worker, Palliative Care Practitioner,
Social Entrepreneur, Trainer and Facilitator and Disability
Management Specialist
• Educate patients on palliative care and when it should be implemented
• Dispel the myths around end of life care
• Educate patients and families on Organ Donation Consent
• Educate patents and families regarding living wills and legality of “D.N.R forms”
• Facilitate referrals for patients and families to palliative care services
13. Context and
Rationale
Acromegaly & Cushings patient day 2017
First ever Acromegaly & Cushings Patient Day, proudly sponsored by Novartis.
This event brought together 22 people across SA – of which 6 were Acromegaly patients and were 3 Cushings patients - for an
informative, supportive, patient focused meeting.
The speaker line up included talks from Genetic Counsellor, Sarah Walters, CEO of Rare Diseases South Africa, Kelly du Plessis and
Academic Researcher, Dr Helen Malherbe from Genetic Alliance, who covered topics such as genetic counselling and the
importance thereof, advocating for patients with rare diseases and the benefits of a support group.
IMPACT
• Share organisational and advocacy knowledge in terms
of access to treatment.
• Provide information on the diseases and treatment
outcomes
• Provide motivation and support those newly
diagnosed.
• Raise awareness
• Provide a platform for patients and advocates to
interact and role-play when communicating their story.
• Reduced stigma
14. Context and
Rationale
Patient family day 2018
RDSA has realised the value of community and often aims to provide an opportunity for our patients and their families to meet and
connect with others in our rare disease community.
Where: Tembali Party Park, Chartwell, Johannesburg
Who attended: 108 patients and family members attended this occasion
MC: Nicole Capper, Rare Diseases Ambassador and WarriorMom
“Alone, we can do so little; together, we can do so
much” ~ Helen Keller
15. Context and
Rationale
“OPEN MEWHEN” letter initiative – Mandela day 2018
In celebration of Mandela Day we encouraged our members to participate in our "Open me when" letter initiative, which will give love,
encouragement and support to our vulnerable community when most needed.
The concept is simple – write a letter or create a small care package for any 6 or 7 of the listed ‘situations’ which rare disease patients
may encounter and for which your letter and words of strength and motivation will make an enormous difference. Rare Diseases South
Africa will provide the name, age and short biography on the patients for whom your letters/packages will be sent.
The letters need to be addressed for the following
'open me when’ occasions:
Open when needing motivation
Open when you need to smile
Open when you’re having a great day
Open on your birthday
Open when you are scared
Open when you are in hospital
Open when you are hungry
IMPACT
• 112 Patients emotionally supported
• Created awareness
• Allowed members of public to “get involved”
16. Context and
Rationale
Rare Diamond Awards - 2017
Goal: Recognise excellence in advancement of overall healthcare, treatment and support offered by all those working within
the Rare Diseases space in South Africa as well as individuals that have made a positive impact on the rare disease community.
Award Attendees: 138 Nominations Received: 77
Rare Diamond Winners
Rare Diamond in Advocacy – Dr Helen Malherbe honouring her commitment to ensure our patients' needs remain top priority and
that congenital disorders remain top of mind for policy-makers.
Rare Diamond in Healthcare – Dr Fiona Kritzinger for advancing patient centred care transforming health care in South Africa.
Rare Diamond Project – Iris House for who have led and implemented innovative projects that deliver better health care solutions in
the paediatric hospice space.
Rare Diamond Support Group: CureSMA for their commitment to support and work closely with people affected by Spinal Muscular
Atrophy.
Rare Diamond Tribute – Melissa Platt, on behalf of Samuel Frederick Platt whose legacy continues to change the way palliative care
is seen and offered to those at end of life.
Rare Warrior – Ashleigh Paterson honouring her life as a rare patient and her positive attitude and ability to live beyond her
diagnosis.
IMPACT
• Developed Champions for Rare Diseases SA
• Increased awareness and created a public profile for those positively impacting our community
• Benefit from a better sense of community
17. Context and
Rationale
Denim Walk 2019
Rare Diseases South Africa (RDSA), in conjunction with the Genetic Alliance South Africa (GA-SA), supported those affected by rare
diseases or at risk of genetic disorders by hosting a Denim Walk.
Goal: Aimed at increasing the visibility of rare diseases and congenital disorders among the public and connecting the
community, patients, their families, and support groups, to raise funds and awareness for both causes.
Route Distances: 1.5km (wheelchair friendly), 2km; 2.5km
Participants: Adults: 166 Visitors – Children: 32MarketVendors:15
Sponsors: Novartis, MixFM (Broadcast live from the gardens / interviewed RDSA CEO, Kelly du Plessis
and RDSA 2019 Brand Champion, Roxy Burger)
IMPACT
• Increased public awareness
• Increased brand awareness
• Raised Funds – R10 030,70 (after expenses)
• Allowed members of public to “get involved”
18. Rare Disease Day 2014-2019
RDSA is the official host of Rare Disease Day in South Africa. Taking place on the last day of February every year, this is the one day
when all patients and families stand together united to educate those around us about our plight.
The denim ribbon is a perfect universal sign for rare and genetic disease awareness: Both are universal, come in pairs and are unique to
the individual. In addition, blue is the colour of strength and the blue jeans denim ribbon is an ideal symbol that expresses solidarity and
a simple concept that anyone can embrace to raise awareness and funds for rare and genetic disorders.
IMPACT
• Increased public awareness
• Increased brand awareness
• Raised Funds – R350 000 in 5 years
• Allowed members of public to “get involved”
#ShowYourRare
20. Context and
Rationale
Generation Rare - Support group incubation
Incubate (v.) grow under conditions that promote development.
Goal: taking nascent and budding support groups, and generating them into being fully fledged, independent patient advocacy
groups able to better support and advocate for patients impacted by their focus area.
Inputs for critical success:
• Furnished office space including desks and access to
boardroom facilities
• IT infrastructure & support:Wi-Fi, printers and phones
• Linkages with reputable suppliers
• Registration with all formal charitable entities (SARS /
CIPC / Department of Social Development)
• Legal & financial support for compliance issues
• Fundraising mechanisms
• Staff to assist with mentorship
SA support groups that have been supported
• Prader-Willi Association of SA
• Sickle Cell Support SA
• Olive Children’s Foundation
• Pulmonary Hypertension Association of SA
• Lysosomal Storage Disorders SA
• CureSMA
• FOP SA
• EDS Support SA
International Groups
• Rare Diseases Kenya
• Rare Diseases Botswana
• Rare Diseases Ghana
• Rare Diseases Zimbabwe
• Okanti Foundation (Namibia)
IMPACT
• Strengthened patient advocacy groups
• United voice across the health sector
• Collaborative input on advocacy efforts
• Sustainable emotional support for patients
21. Context and
Rationale
Patient Group Huddle – 2017/2018
In partnership with Genetic Alliance SA and Campaigning for Cancer.
Goal: Bring together local and regional patient advocacy leaders and nascent patient groups and individual patients and caregiver
advocates to assist with:
• Share organizational and advocacy knowledge and skill as part of on-going capacity building aims of more established or umbrella
patient groups.
• Connect nascent groups and new patient advocates with resources to assist in their development.
• Provide peer exchange and input from subject matter experts.
• Provide a platform for patients and advocates to interact and role-play when communicating their story.
• To provide motivation and support those newly exploring advocacy.
2018 Huddle
Attendees: 56 patient advocates
Venue: RareX 2018
African Countries Represented: 14
2017 Huddle
Attendees: 98 patient advocates
Venue: Premier Hotel – ORTambo
African Countries Represented: 8
IMPACT
• Strengthening of patient advocacy groups across Africa
• Empowered patient advocates with improved knowledge
• Increased capacity across the healthcare sector
23. Context and
Rationale
Brand Champions
Goal: Identify members of the Rare Disease community who are well placed to build awareness and represent
RDSA in the media.
Oscar von Memerty
Oscar is a MPSVI patient and went around
the country with RDSA in 2015, educating
schools and corporates on Rare diseases.
Focus: Stigma and bullying associated with
Rare Diseases
IMPACT
• Raising awareness on Rare Diseases and pertinent challenges on a peer-to-peer scale
• Brand Awareness and visibility
• Encourage critical mass and buy-in from general members of the public
Nicole Capper
Nicole is a #MedicalMomma to daughter,Tatum ,
who was diagnosed with Cystic Fibrosis. Nicole has
gone on to become Mrs South Africa, as well as
being a contestant on SurvivorSA as our brand
ambassador. Focus: Addressing the challenges
around invisible illnesses.
Roxy Burger
Roxy Burger is a #WarriorMom to daughter,
Adrienne, who was diagnosedCongenital
Hyperthyroidism at birth after newborn-screening
being performed.
Focus: Benefits of Newborn screening as well as that
Rare diseases can be treated with inexpensive,
effective treatments.
24. Context and
Rationale
Surveys and Polls
Goal: Identify and understand challenges and pathways impacting the Rare Disease community
IMPACT
• Improved understanding and knowledge base
• Increased patient –centricity
• Sharing of best practice
• Improved patient navigation
25. Context and
Rationale
Disease specific awareness days
Goal: Promote knowledge and awareness on a specific disease within the public at large.
IMPACT
• Improved Peer-to-peer support
• Sharing of best practice
• Improved patient navigation
• Increased awareness
26. Context and
Rationale
Disease specific ambassadors
Goal: Promote knowledge and awareness on a specific disease on a peer-to-peer platform.
IMPACT
• Improved Peer-to-peer support
• Sharing of best practice
• Improved patient navigation
• Increased awareness
RDSA knows that there is no better expert on a rare condition than a
patient themselves which is why we make ambassadors of those who are
energetic, passionate want to be patient experts who then lead the
community.
These ambassadors are tasked with:
- Engaging with community on peer-to-peer level
- Identifying unique challenges experienced by the community and
raising this with RDSA
- Providing responsible information and education to patients
- Monitoring communication platforms
- Identifying patients in need of further referrals
- Representing RDSA at disease specific meetings and conferences
• Gathering consensus on general advocacy activities for inclusion
29. IMPACT
#Ride4Rare
Ride
947 – 2012
Riders: 122
Funds: R120k 947 – 2013
Riders: 202
Funds: R300k
947 - 2014
Riders: 156
Finds: R380k
947 – 2015
Riders: 198
Funds: R487k
Cape Town Cycle
Challenge 2016
Riders: 40
R125 000
947 – 2016
Riders: 156
Funds: R530k
Cape Town Cycle
Challenge 2017
Riders: 40
R56 000
#Ride4Rare
@The Cape Epic
Riders: 2
Funds: R16 000
947 – 2017
Riders: 120
Funds: R630k
947 – 2018
Riders: 130
Funds: R480k
Number of Riders: 1166
Total Amount Raised: R3 124 000
Awareness: 162 000 people
1 patient positively identified and started
treatment as result of our team.
30. #Swim4Sadie (in memory of Sadie Penn)
Swim
SunCity Swim
2014
Funds:
R42,968
Midmar 2015
Funds:
R23,727
SunCity Swim
2015
Funds:
R15,000
Irma Swims 12
miles Funds:
R26 000
Midmar 2015
Funds:
R6,746
Vanderkloof
#Madswimmer
Funds:
R40,000
Midmar 2017
Funds:
R20,895
SunCity 2017
Funds:
R4,460
Midmar 2018
Funds:
R21,425
Orange River
Dash
#MadSwimmer
Funds:
R81,000
SunCity Swim
2018
Funds:
R2,850
Midmar 2019
Funds:
R4,030
IMPACT
Number of Swimmers: 64
Total Amount Raised: R289 101
Awareness: 9 750 people
31. #Run4Rare
Run
OMTOM 2016
Runners: 20
Funds:
R169,000 Walk the Talk
2016
Walkers: 60
Funds:
R45,000
OMTOM 2017
Runners 40
Funds:
R50,000
Walk the Talk
2017
Walkers: 56
Funds:
R50,000OMTOM 2018
Runners: 40
Funds:
R60,000
Run4Rare 2018
(Haileys Halo)
Funds:
R25,000
OMTOM 2019
Runner: 54
Funds:
R81,000
Run4Rare 2019
(Haileys Halo)
Funds:
R30,000
IMPACT
Number of Runners: 270
Total Amount Raised: R540 000 Awareness:
45 000 people
32. #Raise4Rare
Ad-hoc
Projects
Footprints4S
am
R26 164 Eli Rylee
Support
Fund
R16 613
Saving
Candice
Castle
R115 278
Help Thozi
get mobile
R35 505
Patient
Projects
R108 683
#Rare
Heights with
Mrs SA
R17 542
Juan’s
Journey of a
lifetime
R47 875
Love Jenna
R16 578
Miles4
Myasthenia
R13 711
Olive
Children’s
Foundation
R277 832
Fundraising 4
Finn
R62 754
IMPACT
Number of Projects: 11
Total Amount Raised: R738 715
Awareness: 45 000 people
Total Raised through GivenGain:
R1 241 099
Fundraisers: 20
Campaigns: 27
Donors: 1021
33. R.A.R.E ACTIVists
Encouraging members of the public to ride /run / swim for a purpose, by using their mobility to benefit
those without it, through FUNdraising and creating awareness.
Goals:
• Raised Funds for RDSA
• Create awareness and educate members of the public about Rare Diseases
• Brand Awareness
• Provide friends and family of rare disease patients, a platform to turn their feeling of helplessness into
something positive that benefits our rare community.
IMPACT
• Fundraising totalling R4 691 000
• Recruited over 1500 Rare ACTIVists
• Raised awareness to over 210 000 South Africans
34. Impact Summary
Advocacy
Rare Diseases
Forum for private
sector
Improved
collaboration
Strengthened
Advocacy
Increased
visibility
Increased
capacity
Local &
International
participation
UnitedVoice
Increased
capacity
Educated
stakeholders
Education
Improved patient
centricity
Educated all
stakeholders
Sharing of best
practice
Connected
community
Provided
networking
opportunities
Improved
knowledge base
Improved referral
pathways
Increased patient
support Community
Sharing of
knowledge
Improved patient
resources
Connected
community
Motivated
patients
Reduced stigma
Allowed personal
giving from the
public
Provided
networking
platform
Raised awareness
Develop Key
messaging
Capacity
Strengthened
patient advocacy
groups
United voice
Improved
collaboration
Prevent Burnout
Improved
sustainability
Empowered
patient
advocates
Improved
knowledge
Increased
capacity across
the healthcare
sector
Awareness
Raise awareness
on pertinent
challenges on a
peer-to-peer
scale
Increase
Awareness and
visibility
Encourage
critical mass
Improved
understanding
and knowledge
base
Increased
patient –
centricity
Shared best
practice
Improved patient
navigation
ACTIVists
Increased
awareness
Increased
visibility
Increased
Funding
Improved Brand
awareness
PR and Media
exposure
Opportunity for
personal giving
Increased
networking
Community
engagement
Reduce stigma